Bank of New York Mellon’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $418K | Buy |
|
|||||
|
2025
Q2 | $306K | Buy |
|
|||||
|
2025
Q1 | $20.8K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $289K | Sell |
|
|||||
|
2023
Q4 | $296K | Buy |
|
|||||
|
2023
Q3 | $1.66M | Buy |
|
|||||
|
2023
Q2 | $2.51M | Buy |
|
|||||
|
2023
Q1 | $1.86M | Sell |
|
|||||
|
2022
Q4 | $3.65M | Sell |
|
|||||
|
2022
Q3 | $3.68M | Buy |
|
|||||
|
2022
Q2 | $2.82M | Buy |
|
|||||
|
2022
Q1 | $3.2M | Sell |
|
|||||
|
2021
Q4 | $2.71M | Buy |
|
|||||
|
2021
Q3 | $3.28M | Buy |
|
|||||
|
2021
Q2 | $2.38M | Buy |
|
|||||
|
2021
Q1 | $2.8M | Buy |
|
|||||
|
2020
Q4 | $677K | Sell |
|
|||||
|
2020
Q3 | $281K | Hold |
|
|||||
|
2020
Q2 | $176K | Sell |
|
|||||
|
2020
Q1 | $227K | Sell |
|
|||||
|
2019
Q4 | $415K | Buy |
|
|||||
|
2019
Q3 | $134K | Sell |
|
|||||
|
2019
Q2 | $362K | Sell |
|
|||||
|
2019
Q1 | $1.23M | Buy |
|
|||||
|
2018
Q4 | $1.46M | Sell |
|
|||||
|
2018
Q3 | $6.12M | Sell |
|
|||||
|
2018
Q2 | $8.45M | Buy |
|
|||||
|
2018
Q1 | $6.86M | Buy |
|
|||||
|
2017
Q4 | $6.72M | Buy |
|
|||||
|
2017
Q3 | $2.84M | Buy |
|
|||||
|
2017
Q2 | $2.39M | Buy |
|
|||||
|
2017
Q1 | $2.63M | Sell |
|
|||||
|
2016
Q4 | $3.12M | Buy |
|
|||||
|
2016
Q3 | $1.2M | Buy |
|
|||||
|
2016
Q2 | $652K | Buy |
|
|||||
|
2016
Q1 | $294K | Buy |
|
|||||
|
2015
Q4 | $385K | Buy |
|